Table 1. Baseline demographics – clinical characteristics, laboratory and angiographic parameters.
Abbreviations: FSG, fasting serum glucose; WBC, white blood cells; TChol, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; CRP, C-reactive protein; FGF21, fibroblast growth factor 21; LVEF, left ventricular ejection fraction, SAP, Stable angina pectoris.
| Baseline demographics and clinicalcharacteristics | SAP group (lesion +)<br>(n=78) | Control group (lesion -)<br>(n=40) | p value |
|---|---|---|---|
| Age (y) | 63.29 ± 10.79 | 58.88 ± 11.49 | 0.04 |
| Males, n (%) | 58 (74%) | 21 (53%) | 0.015 |
| Hypertension, n (%) | 46 (58%) | 24 (60%) | 0.915 |
| Diabetes Mellitus, n (%) | 29 (37%) | 12 (30%) | 0.438 |
| Smoking, n (%) | 17 (21%) | 7 (18%) | 0.583 |
| LVEF (%) | 53.45 ± 9.16 | 57.03 ± 6.23 | 0.03 |
| Laboratory data | |||
| FSG (mmol/L) | 7.04 ± 2.73 | 6.64 ± 1.92 | 0.41 |
| Creatinine (mmol/L) | 88.4 ± 75.14 | 87.51 ± 27.40 | 0.51 |
| Haemoglobin (g/L) | 133.2 ± 19.0 | 135.3 ± 17.3 | 0.56 |
| WBC (×109/L) | 9.34 ± 2.86 | 9.21 ± 2.89 | 0.82 |
| TChol (mmol/L) | 4.62 ± 1.32 | 4.91 ± 1.60 | 0.29 |
| LDL-C (mmol/L) | 2.74 ± 1.15 | 2.79 ± 1.29 | 0.85 |
| HDL-C (mmol/L) | 1.08 ± 0.30 | 1.42 ± 0.89 | <0.00 |
| TG (mmol/L) | 1.79 ± 1.24 | 1.65 ± 0.99 | 0.54 |
| CRP (mg/mL) | 12.9 ± 27.1 | 5.8 ± 5.2 | 0.12 |
| FGF21 (pg/mL) | 101.18 ± 141.62 | 47.93 ± 58.74 | 0.03 |
| Angiographic data | |||
| SYNTAX score | 23.80 ± 9.53 | ||
| GENSINI score | 50.01 ± 32.15 | ||